Share This Page

Support & Insight for the Autumn of Life

News

Leqembi and Kisunla

Kisunla Vs. Leqembi – The New Alzheimer’s Drugs

Two breakthrough drugs, Leqembi and Kisunla, are the first to actually slow down Alzheimer's. How do they compare to each other?

Kisunla Approved by FDA, 2nd Drug to Actually Slow Alzheimer’s

VIDEO + ARTICLE: Kisunla (generic name: Donanemab) slowed cognitive and functional decline 35%. Once-monthly infusions reduced Alzheimer's plaque 84%.

Unlocking Terazosin’s Potential for Dementia with Lewy Bodies

Three FDA-Approved drugs, terazosin, doxazosin, and alfuzosin, have a happy side effect; they boost energy production in brain cells. New studies suggest this slows or prevents Dementia with Lewy Bodies.

Making it Easier to Take Leqembi for Alzheimer’s

A drug for Alzheimer’s, called Leqembi, might soon be given less often. Right now, patients get it through a drip every two weeks. The idea is to change this to once a month.

FDA Endorses Donanemab, Revolutionary Alzheimer’s Treatment

The unanimous 11-0 FDA vote clears an exciting path for this new Alzheimer's drug.

LEQEMBI® for Alzheimer’s Now in USA, China, Japan, South Korea

South Korea joined other countries in approving LEQEMBI® (generic lecanemab) for mild cognitive impairment, mild and early Alzheimer's. Learn how Leqembi is treating Alzheimer's around the world.

Bigger is Better: Brain Size Up 7%, Dementia Down 25%

In a span of 40 years, why did average brain size increase and dementia rates drop? A new UC-Davis study explores environmental factors behind this silent revolution.

Seroquel-quetiapine Prescriptions Drop 15% After Dementia Warning

"People with dementia living in nursing homes and in the community were prescribed less and we did not detect negative health impacts for these groups."

Leqembi Injection, an Easier Alzheimer’s Treatment, Awaits FDA Approval

LEQEMBI® is the newest Alzheimer's drug. It is administered in hospitals via IV. Biogen applied to the FDA for approval of a home version using an "Autoinjector". See how it works and learn its advantages.

Carolyn Davis Talks About Her Leqembi Infusions

The newest and most promising drug to fight Alzheimer's is Leqembi. Carolyn Davis is giving it a try. Learn about the promise, the risks and how it has restored her hope,

Brain Health Academy Launched by UsAgainstAlzheimer’s

Scheduled to begin on May 9, 2024, six new monthly sessions are now available in this free Continuing Education Program.

Wire Fraud Victim with Alzheimer’s Wins Citibank Lawsuit

People with dementia may be even more vulnerable to fraud and scams than previously thought, according to an NIA study. See the story of one victim with a happy ending. Read the research.
Edited by:
Picture of P. Berger

P. Berger

This site was inspired by my Mom’s autoimmune dementia.

It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.

The site is dedicated to all those preserving the dignity of the community of people living with dementia.

Peter Berger, Editor

Share this page To

Related:

Share to Facebook
Twitter
LinkedIn

This site was inspired by my Mom’s autoimmune dementia.

It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.

The site is dedicated to all those preserving the dignity of the community of people living with dementia.

Peter Berger, Editor

Visit Alzheimer's Weekly On

News, Treatments, Care Tips, Diet

Alzheimer's & Dementia Weekly Newsletter: Free

Free. Care & Treatment. Research & Prevention

This site was inspired by my Mom’s autoimmune dementia.

It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. It has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.

The site is dedicated to all those preserving the dignity of the community of people living with dementia.

Peter Berger, Editor

News to Get at the Truth

Subscribe To Our Weekly Newsletter